NetworkNewsBreaks

WednesdayJul 01, 2020 9:30 am

NetworkNewsBreaks – LexaGene Holdings, Inc. (TSX.V: LXG) (OTCQB: LXXGF) Provides Update on Development Plans for Its Flagship Pathogen Detection Platform

LexaGene Holdings (TSX.V: LXG) (OTCQB: LXXGF), a biotechnology company that develops genetic analyzers for rapid pathogen detection and other molecular markers, today provided an update on development plans of its flagship pathogen detection platform for the human clinical, veterinary diagnostics and food safety sectors. As previously announced, LexaGene has recently placed a pre-commercial unit of its “LX Analyzer” in a major U.S. hospital laboratory for the testing of COVID-19, as well as submitted its plan to the FDA for Emergency Use Authorization (“EUA”). “The analyzer’s multiplex testing capability is an important part of future testing needs, especially if the anticipated…

Continue Reading

WednesdayJul 01, 2020 9:00 am

NetworkNewsBreaks – GoldHaven Resources Corp. (CSE: GOH) Reports Phase One Results from Adam West 2020 Exploration Program

GoldHaven Resources (CSE: GOH) (formerly Altum Resources Corp.), a Canada-based company engaged in the business of acquiring and exploring mineral resource properties, on Monday announced results from the first phase of its 2020 exploration program on its Adam West property located on northern Vancouver Island. The exploration program involved the collection of 109 grab samples and 200 soil samples. Among other highlights, the 2020 program resulted in the successful discovery of the Sisters Copper showing, with peak values of 46.4% Cu and 144 g/t Ag, and the extension of Adam West copper zone. Additionally, the mapping of the Lucky Jim…

Continue Reading

TuesdayJun 30, 2020 2:11 pm

NetworkNewsBreaks – Revance Therapeutics Inc. (NASDAQ: RVNC) Featured in Mizuho Securities Research Report

Revance Therapeutics Inc. (NASDAQ: RVNC) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “Revance announced positive results from two phase 2a open-label, dose escalation studies of DAXI for dynamic forehead following glabellar line injections, and lateral canthal lines (crow's feet). We believe the news is incrementally positive for the company, and we reaffirm our Buy rating and $35 price target.” To request access to the full report, visit http://nnw.fm/SaZ9d About Revance Therapeutics Inc. Revance Therapeutics Inc. is a biotechnology company focused on innovative aesthetic and therapeutic offerings, including its next-generation neuromodulator…

Continue Reading

TuesdayJun 30, 2020 1:53 pm

NetworkNewsBreaks – ISW Holdings, Inc. (ISWH) Announces Official Corporate Name Change

ISW Holdings (OTC: ISWH), a global brand management holdings company, today announced that the Financial Industry Regulatory Authority, Inc. (“FINRA”) has approved the Company’s official name change to “ISW Holdings, Inc.” (from “International Spirits & Wellness Holdings, Inc.”). “We are now manifestly a diversified global brand management holdings company, with active commercial interests spanning the wellness, renewable energy, home healthcare, digital colocation, spirits and cryptocurrency mining sectors,” Alonzo Pierce, president and chairman of ISW Holdings, stated in the news release. “This name change simply reflects the need to bring our company name into alignment with our underlying narrative and strategic…

Continue Reading

TuesdayJun 30, 2020 12:41 pm

NetworkNewsBreaks – Bullfrog Gold Corp. (CSE: BFG) (OTCQB: BFGC) (FSE: 11B) Announces Assay Results on 9 More Holes Drilled at Nevada Project

Bullfrog Gold Corp. (CSE: BFG) (OTCQB: BFGC) (FSE: 11B) today announced gold and silver assay results from nine more of the 25 holes recently drilled at its Bullfrog Project (“Project”). Among key highlights, the update reads, “Drilling continued to intercept thick intervals of gold mineralization in the Mystery Hill (MH) deposit. BH 20-6 intersected 110 meters averaging 0.41 g gold/t, including 26 meters of 0.91 g/t. BH-20-9 intersected 91 meters averaging 0.33 g/t and an upper interval of 6 meters averaging 0.53 at 23 meters. Most of the new intercepts are not in areas previously included in measured and indicated…

Continue Reading

TuesdayJun 30, 2020 12:04 pm

NetworkNewsBreaks – iClick Interactive Asia Group Limited (NASDAQ: ICLK) Recognized for Big Data in Advertising at SBR’s Technology Excellence Awards 2020

iClick Interactive Asia Group (NASDAQ: ICLK), an independent online marketing and enterprise data solutions provider in China, today announced that it has been named winner of the Big Data Award in the advertising category at Singapore Business Review's ("SBR") second Technology Excellence Awards 2020. Held annually by SBR, a leading business magazine serving Singapore's dynamic business community, the Technology Excellence Awards recognize outstanding companies worldwide that have made exceptional contributions in pursuit of technological innovation. "We are thrilled to receive this award from Singapore Business Review which further recognizes iClick's leadership in the international digital marketing industry," Jian "T.J." Tang,…

Continue Reading

TuesdayJun 30, 2020 11:45 am

NetworkNewsBreaks – PowerBand Solutions Inc.’s (TSX.V: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA) Efforts to Simplify, Modernize Car Buying Featured in Exclusive Interview

PowerBand Solutions (TSX.V: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA) today announced that its CEO, Kelly Jennings, has been featured in an exclusive audio interview with NetworkNewsWire (“NNW”), a financial news and content distribution company and one of 45+ brands in the InvestorBrandNetwork (“IBN”). During the interview, Jennings discussed his automotive industry experience, as well as PowerBand’s ongoing efforts to simplify and modernize car buying for consumers. PowerBand is focused on streamlining the car buying process through introducing solutions that benefit “the consumer, the dealer, the funding source and the OEMs.” “One of the bigger milestones was, we took our solution and…

Continue Reading

TuesdayJun 30, 2020 11:23 am

NetworkNewsBreaks – Pressure BioSciences, Inc. (PBIO) and Leica Microsystems Collaborate to Offer Innovative Combined Workflow Expected to Accelerate Cancer R&D

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries, today announced its entry into a worldwide co-marketing agreement with German-based Leica Microsystems CMS GmbH, a Danaher company. Per the update, the historic alliance is expected to offer transformative new empowerment to cancer research worldwide through integrating the latest enabling technologies in capturing, isolating and preparing biopsy samples for superior analysis of relevant biomarkers of disease state and treatment response. "The generation of reliable and reproducible data from biopsy samples is difficult, as it requires…

Continue Reading

TuesdayJun 30, 2020 10:55 am

NetworkNewsBreaks – Cannabis Global, Inc. (MCTC) Launches Newest Line of Branded Products – “Hemp & Booch” Super Premium Kombucha

Cannabis Global (OTC: MCTC), a cannabinoid and hemp extract science-forward company developing infusion and delivery technologies, today announced the launch of its newest line of branded products, Hemp & Booch Super Premium hemp-infused Kombucha. A revolution in the Kombucha beverage market, the product line is based on the finest ingredients available and powered by the Company's Hemp You Can Feel(TM) infusions. "Hemp & Booch not only sets the standard for taste and purity, but also for the relaxing effect provided by the Company's patent pending Hemp You Can Feel(TM) infusions," Arman Tabatabaei, Cannabis Global CEO, stated in the news release.…

Continue Reading

TuesdayJun 30, 2020 10:31 am

NetworkNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Secures $2.2M Through Warrant Exercise

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, on Monday announced the closing of its previously announced transaction. According to the update, Predictive Oncology secured approximately $2.2 million in gross cash proceeds from the transaction, prior to deducting placement agent fees and offering expenses, through the exercise of certain existing warrants by several holders to purchase an aggregate of up to 1,396,826 shares of common stock, each at an exercise price of $1.575. The shares of common stock issued upon exercise of the existing warrants are registered for resale…

Continue Reading